171 related articles for article (PubMed ID: 7640219)
1. Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
Scambia G; Benedetti-Panici P; Ferrandina G; Distefano M; Salerno G; Romanini ME; Fagotti A; Mancuso S
Br J Cancer; 1995 Aug; 72(2):361-6. PubMed ID: 7640219
[TBL] [Abstract][Full Text] [Related]
2. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
3. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Distefano M; Salerno G; Romanini ME; d'Agostino G; Fagotti A; Mancuso S
Ann N Y Acad Sci; 1996 Apr; 784():202-8. PubMed ID: 8651570
[No Abstract] [Full Text] [Related]
5. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
van der Burg ME; Henzen-Logmans SC; Foekens JA; Berns EM; Rodenburg CJ; van Putten WL; Klijn JG
Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
[TBL] [Abstract][Full Text] [Related]
6. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of epidermal growth factor receptor in node-positive breast cancer.
Grimaux M; Romain S; Remvikos Y; Martin PM; Magdelénat H
Breast Cancer Res Treat; 1989 Oct; 14(1):77-90. PubMed ID: 2690971
[TBL] [Abstract][Full Text] [Related]
8. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone receptors and long term survival in invasive ovarian cancer.
Münstedt K; Steen J; Knauf AG; Buch T; von Georgi R; Franke FE
Cancer; 2000 Oct; 89(8):1783-91. PubMed ID: 11042574
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone and epidermal growth factor receptors in meningiomas.
Horsfall DJ; Goldsmith KG; Ricciardelli C; Skinner JM; Tilley WD; Marshall VR
Aust N Z J Surg; 1989 Nov; 59(11):881-8. PubMed ID: 2818349
[TBL] [Abstract][Full Text] [Related]
11. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
Geyer H; Teufel G; de Gregorio G; Pfleiderer A
Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure.
Goff BA; Ries JA; Els LP; Coltrera MD; Gown AM
Gynecol Oncol; 1998 Sep; 70(3):378-85. PubMed ID: 9790791
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
Br J Cancer; 1991 Jul; 64(1):182-4. PubMed ID: 1854619
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers.
Bolla M; Chedin M; Colonna M; Marron J; Rostaing-Puissant B; Chambaz E
Eur J Cancer; 1992; 28A(6-7):1052-4. PubMed ID: 1627373
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
[TBL] [Abstract][Full Text] [Related]
17. Relations between epidermal growth factor receptor and oestrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients in Kuwait.
Nasralla MY; Paszko Z; Omar YT; Ali MA; al Jazzaf H; Padzik H; Temmim L
Eur J Cancer; 1992; 29A(1):76-81. PubMed ID: 1445750
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of EGFR in invasive breast cancer.
Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
Yeh TS; Jan YY; Chiu CT; Ho YB; Chen TC; Lee KF; Chan KM; Hsu JC; Hwang TL; Chen MF
Gut; 2002 Nov; 51(5):712-6. PubMed ID: 12377812
[TBL] [Abstract][Full Text] [Related]
20. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.
Sainsbury JR; Farndon JR; Needham GK; Malcolm AJ; Harris AL
Lancet; 1987 Jun; 1(8547):1398-402. PubMed ID: 2884496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]